Method of preselection patients for antiVEGF, anti-HIF-1 or anti-thioredoxin therapy

Details for Australian Patent Application No. 2005277350 (hide)

Owner Arizona Board of Regents on behalf of the University of Arizona Prolx Pharmaceuticals, Corp.

Inventors Gillies, Robert J.; Jordan, Benedicte; Powis, Garth; Kirkpatrick, Lynn; Kirkpatrick, D. Lynn

Agent Pizzeys

Pub. Number AU-A-2005277350

PCT Pub. Number WO2006/023658

Priority 60/602,151 17.08.04 US; 60/602,163 17.08.04 US

Filing date 17 August 2005

Wipo publication date 2 March 2006

International Classifications

A61K 49/00 (2006.01) Preparations for testing

Event Publications

1 March 2007 PCT application entered the National Phase

  PCT publication WO2006/023658 Priority application(s): WO2006/023658

17 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005277351-Novel polymorphs of azabicyclohexane

2005277343-Extended treatment of multiple sclerosis